IL1B and idiopathic pulmonary fibrosis: Instead of simulating IPF disease models with TGF-β alone [33], we treated MRC-5 (human embryonic lung fibroblasts) with IL-1β and TGF-β (Figure 4A), which was also consistent with previous mRNA expression levels (Figure 1F).